Citation: Cp. Spencer et al., FORTNIGHTLY REVIEW - MANAGEMENT OF ABNORMAL BLEEDING IN WOMEN RECEIVING HORMONE REPLACEMENT THERAPY, BMJ. British medical journal, 315(7099), 1997, pp. 37-42
Authors:
ROSS D
GODFREE V
COOPER A
PRYSEDAVIES J
WHITEHEAD MI
Citation: D. Ross et al., ENDOMETRIAL EFFECTS OF 3 DOSES OF TRIMEGESTONE, A NEW ORALLY-ACTIVE PROGESTOGEN, ON THE POSTMENOPAUSAL ENDOMETRIUM, Maturitas, 28(1), 1997, pp. 83-88
Authors:
ROSS D
COOPER AJ
PRYSEDAVIES J
BERGERON C
COLLINS WP
WHITEHEAD MI
Citation: D. Ross et al., RANDOMIZED, DOUBLE-BLIND, DOSE-RANGING STUDY OF THE ENDOMETRIAL EFFECTS OF A VAGINAL PROGESTERONE GEL IN ESTROGEN-TREATED POSTMENOPAUSAL WOMEN, American journal of obstetrics and gynecology, 177(4), 1997, pp. 937-941
Authors:
LEES B
GARLAND SW
WALTON C
ROSS D
WHITEHEAD MI
STEVENSON JC
Citation: B. Lees et al., ROLE OF ORAL PAMIDRONATE IN PREVENTING BONE LOSS IN POSTMENOPAUSAL WOMEN, Osteoporosis international, 6(6), 1996, pp. 480-485
Authors:
ELLERINGTON MC
HILLARD TC
WHITCROFT SIJ
MARSH MS
LEES B
BANKS LM
WHITEHEAD MI
STEVENSON JC
Citation: Mc. Ellerington et al., INTRANASAL SALMON-CALCITONIN FOR THE PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS, Calcified tissue international, 59(1), 1996, pp. 6-11
Authors:
MARSDEN J
SACKS NPM
BAUM M
WHITEHEAD MI
CROOK D
Citation: J. Marsden et al., RANDOMIZED CLINICAL-TRIAL OF HORMONE REPLACEMENT THERAPY IN PATIENTS WITH BREAST-CANCER - A FEASIBILITY STUDY, British Journal of Cancer, 74, 1996, pp. 12-12
Authors:
HILLARD TC
WHITCROFT SJ
MARSH MS
ELLERINGTON MC
LEES B
WHITEHEAD MI
STEVENSON JC
Citation: Tc. Hillard et al., LONG-TERM EFFECTS OF TRANSDERMAL AND ORAL HORMONE REPLACEMENT THERAPYON POSTMENOPAUSAL BONE LOSS, Osteoporosis international, 4(6), 1994, pp. 341-348
Citation: Ms. Marsh et al., PARADOXICAL EFFECTS OF HORMONE REPLACEMENT THERAPY ON BREAST TENDERNESS IN POSTMENOPAUSAL WOMEN, Maturitas, 19(2), 1994, pp. 97-102
Authors:
BOURNE TH
CAMPBELL S
REYNOLDS K
HAMPSON J
BHATT L
CRAYFORD TJB
WHITEHEAD MI
COLLINS WP
Citation: Th. Bourne et al., THE POTENTIAL ROLE OF SERUM CA-125 IN AN ULTRASOUND-BASED SCREENING-PROGRAM FOR FAMILIAL OVARIAN-CANCER, Gynecologic oncology, 52(3), 1994, pp. 379-385
Authors:
WHITCROFT SI
CROOK D
MARSH MS
ELLERINGTON MC
WHITEHEAD MI
STEVENSON JC
Citation: Si. Whitcroft et al., LONG-TERM EFFECTS OF ORAL AND TRANSDERMAL HORMONE REPLACEMENT THERAPIES ON SERUM-LIPID AND LIPOPROTEIN CONCENTRATIONS, Obstetrics and gynecology, 84(2), 1994, pp. 222-226
Authors:
MARSH MS
CROOK D
WHITCROFT SIJ
WORTHINGTON M
WHITEHEAD MI
STEVENSON JC
Citation: Ms. Marsh et al., EFFECT OF CONTINUOUS COMBINED ESTROGEN AND DESOGESTREL HORMONE REPLACEMENT THERAPY ON SERUM-LIPIDS AND LIPOPROTEINS, Obstetrics and gynecology, 83(1), 1994, pp. 19-23
Authors:
MARSH MS
BOURNE TH
WHITEHEAD MI
COLLINS WP
CAMPBELL S
Citation: Ms. Marsh et al., THE TEMPORAL EFFECT OF PROGESTOGEN ON UTERINE ARTERY PULSATILITY INDEX IN POSTMENOPAUSAL WOMEN RECEIVING SEQUENTIAL HORMONE REPLACEMENT THERAPY, Fertility and sterility, 62(4), 1994, pp. 771-774
Authors:
BOURNE TH
CAMPBELL S
REYNOLDS KM
WHITEHEAD MI
HAMPSON J
ROYSTON P
CRAYFORD TJB
COLLINS WP
Citation: Th. Bourne et al., SCREENING FOR EARLY FAMILIAL OVARIAN-CANCER WITH TRANSVAGINAL ULTRASONOGRAPHY AND COLOR BLOOD-FLOW IMAGING, BMJ. British medical journal, 306(6884), 1993, pp. 1025-1029